Russell Investments Group’s Loxo Oncology, Inc LOXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-14,250
Closed -$2M 3105
2018
Q4
$2M Sell
14,250
-85,234
-86% -$12.9M ﹤0.01% 1617
2018
Q3
$17.1M Buy
99,484
+25,060
+34% +$4.21M 0.03% 665
2018
Q2
$12.9M Buy
74,424
+58,212
+359% +$8.75M 0.03% 763
2018
Q1
$1.87M Buy
16,212
+7,788
+92% +$828K ﹤0.01% 1884
2017
Q4
$728K Sell
8,424
-2,439
-22% -$203K ﹤0.01% 2297
2017
Q3
$1M Sell
10,863
-16,697
-61% -$1.3M ﹤0.01% 2147
2017
Q2
$2.21M Sell
27,560
-7,809
-22% -$433K ﹤0.01% 1679
2017
Q1
$1.49M Sell
35,369
-19,061
-35% -$785K ﹤0.01% 1893
2016
Q4
$1.81M Buy
+54,430
New +$1.4M ﹤0.01% 1856

Other funds holding LOXO

Russell Investments Group's LOXO Position: Q1 2019 in Review

Russell Investments Group sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 14,250 shares — an estimated $2M sold.

Russell Investments Group first reported a position in LOXO in Q4 2016 and held it in 9 quarters. The position peaked at $17.1M in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • Russell Investments Group reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • Russell Investments Group sold 14,250 Loxo Oncology, Inc shares in Q1 2019, an estimated $2M.
  • Russell Investments Group first reported a position in Loxo Oncology, Inc in Q4 2016 and held it in 9 quarters.
  • Russell Investments Group's Loxo Oncology, Inc position peaked at $17.1M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Russell Investments Group's 13F filing for Q1 2019, filed 13 May 2019.